Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation
Gerardo Rosati(Ospedale San Carlo), Domenico Bilancia(Azienda Ospedaliera Ospedale San Carlo Borromeo), Enrico Scarano, Lucia Altucci(Biogem), Rosa Anna Cifarelli, Nunzio Del Gaudio(University of Campania "Luigi Vanvitelli")
Cited by 5
Related Papers
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
|Cell Death and Differentiation|2018|6.6k
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
|Journal of Clinical Oncology|2011|763
The International Human Epigenome Consortium: A Blueprint for Scientific Collaboration and Discovery
|Cell|2016|570
Gemcitabine Plus Vinorelbine Versus Vinorelbine Alone in Elderly Patients With Advanced Non–Small-Cell Lung Cancer
|Journal of Clinical Oncology|2000|452
Apoptotic cell death in disease—Current understanding of the NCCD 2023
|Cell Death and Differentiation|2023|371